The increased risk of disease and decreased capacity to respond to tissue insult in the setting of aging results from complex changes in homeostatic mechanisms, including the regulation of oxidative stress and cellular heterogeneity. In aged skin, the healing capacity is markedly diminished resulting in a high risk for chronic wounds. Stem cell-based therapies have the potential to enhance cutaneous regeneration, largely through trophic and paracrine activity. Candidate cell populations for therapeutic application include adult mesenchymal stem cells, embryonic stem cells and induced pluripotent stem cells. Autologous cell-based approaches are ideal to minimize immune rejection but may be limited by the declining cellular function associated with aging. One strategy to overcome age-related impairments in various stem cell populations is to identify and enrich with functionally superior stem cell subsets via single cell transcriptomics. Another approach is to optimize cell delivery to the harsh environment of aged wounds via scaffold-based cell applications to enhance engraftment and paracrine activity of therapeutic stem cells. In this review, we shed light on challenges and recent advances surrounding stem cell therapies for wound healing and discuss limitations for their clinical adoption.

Keywords:
Aging, Wound healing, Cutaneous regeneration, Stem cells, Progenitor cells
1.
Hayflick L: Biological aging is no longer an unsolved problem. Ann NY Acad Sci 2007;1100:1-13.
2.
Reed MJ, Edelberg JM: Impaired angiogenesis in the aged. Sci Aging Knowledge Environ 2004;2004:pe7.
3.
Rando TA: Stem cells, ageing and the quest for immortality. Nature 2006;441:1080-1086.
4.
Chang EI, et al: Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007;116:2818-2829.
5.
Werdin F, Tenenhaus M, Rennekampff HO: Chronic wound care. Lancet 2008;372:1860-1862.
6.
Finlayson E, et al: Major abdominal surgery in nursing home residents: a national study. Ann Surg 2011;254:921-926.
7.
US Census Bureau: Projections 2012-2060. Washington, US Census Bureau, 2012.
8.
Sen CK, et al: Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009;17:763-771.
9.
Pollack A: A stem-cell-based drug gets approval in Canada. New York Times, May 17, 2012.
10.
European Medicines Agency: First Stem-Cell Therapy Recommended for Approval in EU. London, European Medicines Agency, 2014.
11.
Li MD, Atkins H, Bubela T: The global landscape of stem cell clinical trials. Regen Med 2014;9:27-39.
12.
Rosemann A: Why regenerative stem cell medicine progresses slower than expected. J Cell Biochem 2014;115:2073-2076.
13.
Behr B, et al: Stem cells. Plast Reconstr Surg 2010;126:1163-1171.
14.
Garg RK, et al: Capillary force seeding of hydrogels for adipose-derived stem cell delivery in wounds. Stem Cells Transl Med 2014;3:1079-1089.
15.
Kirana S, et al: Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int J Clin Pract 2012;66:384-393.
16.
Kawamoto A, et al: Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009;27:2857-2864.
17.
Losordo DW, et al: A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv 2012;5:821-830.
18.
Procházka V, et al: Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010;19:1413-1424.
19.
Dominici M, et al: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
20.
Caplan AI, Dennis JE: Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
21.
Falanga V, et al: Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007;13:1299-1312.
22.
Badiavas EV, Falanga V: Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003;139:510-516.
23.
Rustad KC, et al: Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012;33:80-90.
24.
Ren G, et al: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-150.
25.
Hu MS, et al: The role of stem cells during scarless skin wound healing. Adv Wound Care 2014;3:304-314.
26.
Mei SHJ, et al: Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010;182:1047-1057.
27.
Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV: Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-390.
28.
Wu Y, et al: Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648-2659.
29.
Zuk PA, et al: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-228.
30.
Zuk PA, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
31.
Boquest AC, et al: Isolation of stromal stem cells from human adipose tissue. Methods Mol Biol 2006;325:35-46.
32.
Teng M, Huang Y, Zhang Y: Application of stems cells in wound healing - an update: stem cells in wound healing. Wound Repair Regen 2014;22:151-160.
33.
Rigotti G, et al: Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007;119:1409-1422; discussion 1423-1424.
34.
Kolle SF, et al: Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 2013;382:1113-1120.
35.
Bura A, et al: Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy 2014;16:245-257.
36.
Kamolz LP, et al: Cultured human epithelium: human umbilical cord blood stem cells differentiate into keratinocytes under in vitro conditions. Burns 2006;32:16-19.
37.
Liao Y, et al: Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplant 2014;23:303-317.
38.
In ‘t Anker PS, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003;102:1548-1549.
39.
Kim W-S, et al: Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007;48:15-24.
40.
Alviano F, et al: Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007;7:11.
41.
Sanmano B, et al: Engraftment of umbilical cord epithelial cells in athymic mice: in an attempt to improve reconstructed skin equivalents used as epithelial composite. J Dermatol Sci 2005;37:29-39.
42.
Wong VW, et al: Stem cell niches for skin regeneration. Int J Biomater 2012;2012:926059.
43.
Wong VW, Gurtner GC, Longaker MT: Wound healing: a paradigm for regeneration. Mayo Clin Proc 2013;88:1022-1031.
44.
Odorico JS, Kaufman DS, Thomson JA: Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19:193-204.
45.
Guenou H, et al: Human embryonic stem- cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009;374:1745-1753.
46.
Wu DC, Boyd AS, Wood KJ: Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci 2007;12:4525-4535.
47.
Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-876.
48.
Itoh M, et al: Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 2013;8:e77673.
49.
Sebastiano V, et al: Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med 2014;6:264ra163.
50.
Umegaki-Arao N, et al: Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa. Sci Transl Med 2014;6:264ra164.
51.
Yang R, et al: Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells. Nat Commun 2014;5:3071.
52.
Reardon S: Cyranoski, Japan stem-cell trial stirs envy. Nature 2014;513:287-288.
53.
Gurtner GC, et al: Wound repair and regeneration. Nature 2008;453:314-321.
54.
Sharpless NE, DePinho RA: How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007;8:703-713.
55.
Lähteenvuo J, Rosenzweig A: Effects of aging on angiogenesis. Circ Res 2012;110:1252-1264.
56.
Donato AJ, et al: Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell 2008;7:805-812.
57.
Trengove NJ, et al: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-452.
58.
Koenen P, et al: Acute and chronic wound fluids inversely influence adipose-derived stem cell function: molecular insights into impaired wound healing. Int Wound J 2015;12:10-16.
59.
Duscher D, et al: Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells. Sci Rep 2014;4:7144.
60.
Januszyk M, Gurtner GC: High-throughput single-cell analysis for wound healing applications. Adv Wound Care 2013;2:457-469.
61.
Januszyk M, et al: Diabetes irreversibly depletes bone marrow-derived mesenchymal progenitor cell subpopulations. Diabetes 2014;63:3047-3056.
62.
Efimenko A, et al: Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med 2011;9:10.
63.
Duscher D, et al: Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Proc Natl Acad Sci USA 2015;112:94-99.
64.
De Barros S, et al: Aging-related decrease of human ASC angiogenic potential is reversed by hypoxia preconditioning through ROS production. Mol Ther 2013;21:399-408.
65.
Perveen S, et al: Role of EC-SOD overexpression in preserving pulmonary angiogenesis inhibited by oxidative stress. PLoS One 2012;7:e51945.
66.
Wong VW, et al: Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci 2011;11:1458-1466.
67.
Jeon O, Alsberg E: Regulation of stem cell fate in a three-dimensional micropatterned dual-crosslinked hydrogel system. Adv Funct Mater 2013;23:4765-4775.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.